plicamycin has been researched along with Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laurent, G; Leroy, I; Quillet-Mary, A | 1 |
1 other study(ies) available for plicamycin and Leukemia
| Article | Year |
|---|---|
Mithramycin A activates Fas death pathway in leukemic cell lines.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Death Domain Receptor Signaling Adaptor Proteins; Drug Resistance, Neoplasm; Fas Ligand Protein; fas Receptor; Humans; Jurkat Cells; Leukemia; Plicamycin; Signal Transduction | 2006 |